Aprepitant as an Antipruritic Agent?
Open accessThe DOI matches its Crossref record.
Abstract
To the Editor: The Sezary syndrome is a leukemic, cutaneous, epidermotropic T-cell lymphoma. Pruritus, insomnia, and depression impair the quality of life and can lead to suicide.1 Substance P is a key mediator of pruritus.2 An increase in the expression of its receptor, neurokinin-1, has been reported on keratinocytes in pruritic skin diseases.3 Aprepitant is an oral neurokinin-1–receptor antagonist.4 It is widely used as an antiemetic agent in chemotherapy-induced nausea and vomiting.5 However, its action suggests a potential reduction in substance P–induced pruritus, even though pruritus is considered a rare side effect of this drug. We report on three patients . . .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Lysophosphatidic Acid Is a Potential Mediator of Cholestatic Pruritus
Kremer, A. E., Martens, J. J. W. W., Kulik, W., Ruëff, F., Kuiper, E. M. M., van Buuren, H. R., van Erpecum, K. J., Kondrackiene, J., Prieto, J., Rust, C., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.05.009 · Cited by 410
Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?
Mollanazar, N. K., Smith, P. K., & Yosipovitch, G. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8488-5 · Cited by 353
Choi, J. E., & Di Nardo, A. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0675-z · Cited by 331
Targeting the Neurokinin Receptor 1 with Aprepitant: A Novel Antipruritic Strategy
Ständer, S., Siepmann, D., Herrgott, I., Sunderkötter, C., & Luger, T. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010968 · Cited by 293
Steinhoff, M., Suárez, A., Feramisco, J., & Koo, J. (2012) · Acta Dermato Venereologica · doi:10.2340/00015555-1188 · Cited by 263
TRPA1 controls inflammation and pruritogen responses in allergic contact dermatitis
Liu, B., Escalera, J., Balakrishna, S., Fan, L., Caceres, A. I., Robinson, E., Sui, A., McKay, M. C., McAlexander, M. A., Herrick, C. A., et al. (2013) · The FASEB Journal · doi:10.1096/fj.13-229948 · Cited by 232
“Interestingly, a recent case study reported that aprepitant treatment diminished pruritus in patients suffering from Sézary syndrome, a cutaneous T-cell lymphoma associated with severe pruritus (54).”
BackgroundStänder, S., & Luger, T. A. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-662-44605-8_14 · Cited by 67
The NK1 receptor antagonist serlopitant for treatment of chronic pruritus
Ständer, S., Spellman, M. C., Kwon, P., & Yosipovitch, G. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1638910 · Cited by 26
Metadata
- Authors
- Duval, A., & Dubertret, L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-10
- Volume
- 361
- Issue
- 14
- Pages
- 1415-1416
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1990701533
- Cited by
- 136
- References
- 0
- FWCI
- 9.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.